search
Back to results

Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering (EXPEDIT)

Primary Purpose

Colorectal Cancer

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
CRC screening invitation not including the screening test.
Mailing of FIT with invitation
Information letter before invitation
Sponsored by
University Hospital, Caen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Colorectal Cancer focused on measuring Screening, Participation

Eligibility Criteria

50 Years - 74 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 50 to 74 years old Resident of Centre Val de Loire French area Eligible for CRC screening invitation within the biennal CRC-PBOSP during the inclusion period Affiliated to the health insurance scheme Exclusion Criteria: CRC screening exclusion criteria notified to CRCDC-CVL in a previous screening round (family or personal history of CRC/adenoma, inflammatory bowel disease) Colonoscopy in the previous 5 years) Subjects refusing data transmission to research team will be excluded from statistical analyses.

Sites / Locations

  • Crcdc-Cvl

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Other

Experimental

Experimental

Arm Label

Control "C"

Intervention "B1"

Intervention "B2"

Arm Description

Usual care : Screening test (Fecal immunochemical test - FIT) delivery and reminders will be carried out in accordance with the Colorectal cancer population-based organised screening program (CRC-PBOSP) specifications at the time of the study. This arm is suitable for both the first screening round in 50-51 years old population, and for the subsequent screening rounds.

FIT mailed at home within the CRC screening invitation without prior information letter. This arm is suitable for both the first screening round in 50-51 years old population, and for the subsequent screening rounds.

FIT mailed at home within the CRC screening invitation with prior information letter. This arm is suitable for the first screening round in 50-51 years old population only.

Outcomes

Primary Outcome Measures

Participation to CRC screening program
Rate of FIT sent to laboratory for analysis within 16 of months of invitation among invitees.
Performance of colonoscopy in FIT positive patients
Rate of Colonoscopy within 6 months after positive FIT among invitees with a positive FIT

Secondary Outcome Measures

Participation to CRC screening program at 24 months
Rate of FIT sent to laboratory for analysis within 24 of months of invitation among invitees.
Time to screening participation
Time to screening participation within 24 months of invitation among invitees
Colonoscopy in FIT positive patients, 12 months after the positive test
Rate of Colonoscopy within 12 months after positive FIT among invitees with a positive FIT
Time to colonoscopy (in FIT positive patients)
Time from FIT to colonoscopy within 12 months of positive FIT among invitees with a positive FIT
Colonoscopy findings
Rate of colorectal cancer or advanced neaplasia in invitees with a positive FIT
Participation to CRC screening program in first invitees (50-51 yrs-old)
Rate of FIT sent to laboratory for analysis within 16 of months of invitation among first invitees (50-51 yrs-old)
Cost-effectiveness analysis
Costs of CSC-PBOSP from invitation to colonoscopy when necessary

Full Information

First Posted
July 20, 2023
Last Updated
September 4, 2023
Sponsor
University Hospital, Caen
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Centre Régional de Coordination des Dépistages des Cancers (CRCDC) Centre Val de Loire
search

1. Study Identification

Unique Protocol Identification Number
NCT06032338
Brief Title
Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering
Acronym
EXPEDIT
Official Title
EXPérimentation d'Envoi Postal DIrect à Domicile du kiT de dépistage du Cancer Colorectal Sans Commande préalable [Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering]
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 14, 2023 (Anticipated)
Primary Completion Date
March 14, 2025 (Anticipated)
Study Completion Date
November 14, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Caen
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Centre Régional de Coordination des Dépistages des Cancers (CRCDC) Centre Val de Loire

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The effect of mailing FIT with the invitation on participation and colonoscopy rates will be evaluated in a randomized controlled trial conducted in the Centre-Val de Loire (CVL) region, involving 64,000 people from the population eligible for colorectal cancer population-based organised screening program (CRC-PBOSP). In the "C" control group, invitations, test delivery and reminders will be carried out in accordance with the CRC-PBOSP rules at the time of the study. Intervention group "B" will evaluate two experimental modes of invitation with direct home mailing of the test: Method "B1": invitation with test sent to home without prior information letter Method "B2": information letter followed by invitation with test sent home, designed to optimize participation by first-time subjects (aged 50-51) invited to the CRC-PBOSP for the first time. Ancillary studies will focus 1/ on acceptability of this intervention (qualitative study on a few general practitioners, gastroenterologists and invitees), 2/ on social and geographical inequalities of participation on a subsample of individuals included in EXPEDIT study using ecological indices (EDI, SCALE).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
Screening, Participation

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The number of study arms will differ according to age-group: In 50 or 51 yrs age-group, individuals (n=5760 ) will be randomised in 3 groups: C, B1 and B2 (allocation ratio 2:1:1) In the age-group older than 51 yrs, individuals (n=58240) will be randomised in 2 groups: C, and B1 (allocation 1:1) In the main analysis including both age-groups, B1 and B2 arms would be pooled.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
64000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control "C"
Arm Type
Other
Arm Description
Usual care : Screening test (Fecal immunochemical test - FIT) delivery and reminders will be carried out in accordance with the Colorectal cancer population-based organised screening program (CRC-PBOSP) specifications at the time of the study. This arm is suitable for both the first screening round in 50-51 years old population, and for the subsequent screening rounds.
Arm Title
Intervention "B1"
Arm Type
Experimental
Arm Description
FIT mailed at home within the CRC screening invitation without prior information letter. This arm is suitable for both the first screening round in 50-51 years old population, and for the subsequent screening rounds.
Arm Title
Intervention "B2"
Arm Type
Experimental
Arm Description
FIT mailed at home within the CRC screening invitation with prior information letter. This arm is suitable for the first screening round in 50-51 years old population only.
Intervention Type
Other
Intervention Name(s)
CRC screening invitation not including the screening test.
Intervention Description
The invitation to CRC-PBOSP will only contain informations on how to get the screening test.
Intervention Type
Other
Intervention Name(s)
Mailing of FIT with invitation
Intervention Description
The invitation to CRC-PBOSP will contain the CRC screening test.
Intervention Type
Other
Intervention Name(s)
Information letter before invitation
Intervention Description
An information letter will be sent to future invitees a few weeks before the invitation, to announce the mailing of the CRC screening kit.
Primary Outcome Measure Information:
Title
Participation to CRC screening program
Description
Rate of FIT sent to laboratory for analysis within 16 of months of invitation among invitees.
Time Frame
16 months after the invitation
Title
Performance of colonoscopy in FIT positive patients
Description
Rate of Colonoscopy within 6 months after positive FIT among invitees with a positive FIT
Time Frame
6 months after the positive FIT
Secondary Outcome Measure Information:
Title
Participation to CRC screening program at 24 months
Description
Rate of FIT sent to laboratory for analysis within 24 of months of invitation among invitees.
Time Frame
24 months after invitation
Title
Time to screening participation
Description
Time to screening participation within 24 months of invitation among invitees
Time Frame
24 months after invitation
Title
Colonoscopy in FIT positive patients, 12 months after the positive test
Description
Rate of Colonoscopy within 12 months after positive FIT among invitees with a positive FIT
Time Frame
12 months after the positive test
Title
Time to colonoscopy (in FIT positive patients)
Description
Time from FIT to colonoscopy within 12 months of positive FIT among invitees with a positive FIT
Time Frame
12 months after the positive test
Title
Colonoscopy findings
Description
Rate of colorectal cancer or advanced neaplasia in invitees with a positive FIT
Time Frame
12 months after the positive test
Title
Participation to CRC screening program in first invitees (50-51 yrs-old)
Description
Rate of FIT sent to laboratory for analysis within 16 of months of invitation among first invitees (50-51 yrs-old)
Time Frame
16 months after invitation
Title
Cost-effectiveness analysis
Description
Costs of CSC-PBOSP from invitation to colonoscopy when necessary
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
74 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 50 to 74 years old Resident of Centre Val de Loire French area Eligible for CRC screening invitation within the biennal CRC-PBOSP during the inclusion period Affiliated to the health insurance scheme Exclusion Criteria: CRC screening exclusion criteria notified to CRCDC-CVL in a previous screening round (family or personal history of CRC/adenoma, inflammatory bowel disease) Colonoscopy in the previous 5 years) Subjects refusing data transmission to research team will be excluded from statistical analyses.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lydia GUITTET, MD,PhD
Phone
+33(0)231065781
Email
guittet-l@chu-caen.fr
Facility Information:
Facility Name
Crcdc-Cvl
City
Tours
ZIP/Postal Code
37000
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julie BOYARD, ScD
Email
j.boyard@depistage-cancer.fr
First Name & Middle Initial & Last Name & Degree
Julie BOYARD, ScD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering

We'll reach out to this number within 24 hrs